(Total Views: 620)
Posted On: 12/14/2020 3:50:21 PM
Post# of 149272
Quote:
In fact, InCellDx owes CYDY royalties for every kit it sells to measure CCR5 occupancy using our antibody leronlimab.
There are no royalties owed. From the initial deal we would be selling them expired leronlimab. My best guess is at that time we were providing them leronlimab for free because we were the only ones using that test. Leronlimab could be sold on the open market right now for laboratory purposes as far as I know we are not distributing it. Once we are approved IncellDX can buy it across the counter.
(0)
(0)Scroll down for more posts ▼
